Evidence map›Paper›PMID 33687520›Full record

ArticleClinical research in cardiology : official journal of the German Cardiac Society2021

Analysis of causes of death in patients with implanted defibrillators.

Herbert Nägele, Eike Gröene, Daniel Stierle, Matthias P Nägele

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Timely and individualized heart failure management: need for implementation into the new guidelines.Clinical research in cardiology : official journal of the German Cardiac Society · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Herbert NägeleHeart Center, Cardiology Division, Department of Heart Failure and Device Therapy, Albertinen-Krankenhaus, Süntelstraße 11a, 22457, Hamburg, Germany. herbert.naegele@immanuelalbertinen.de.ORCID http://orcid.org/0000-0002-8282-9634
Eike GröeneHeart Center, Cardiology Division, Department of Heart Failure and Device Therapy, Albertinen-Krankenhaus, Süntelstraße 11a, 22457, Hamburg, Germany.
Daniel StierleHeart Center, Cardiology Division, Department of Heart Failure and Device Therapy, Albertinen-Krankenhaus, Süntelstraße 11a, 22457, Hamburg, Germany.
Matthias P NägeleDepartment of Cardiology, University Hospital Zürich, Zurich, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsImplantable cardioverter defibrillators (ICDs) are used for primary or secondary prevention of sudden cardiac death. We sought to clarify prognosis and causes of death after ICD implantation. METHODS AND

resultsA total of 2743 patients with ICDs implanted during 1990-2020 were analyzed. Median age was 68.5 (59.6-74.6) years; 21% women, median left ventricular ejection fraction (LVEF) was 30 (23-35), 52% had an ischemic etiology and 77% had a primary preventive indication. Mortality rate after 10 years was 22, 44, 55, and 72% in the 1st, 2nd, 3rd, and 4

conclusionLife expectancy of ICD patients is lower than for the general population. Mortality is predominantly due to CHF, but there is still a considerable rate of SD. The occurrence of cancers, most importantly bronchial carcinomas, and infections, warrants protective measures. Some deaths during procedures are possibly preventable. Patients with ICDs comprise a vulnerable cohort, and treatment has to be optimized in many directions to improve prognosis.

Indexed as

Defibrillators, ImplantableAgedDeath, Sudden, CardiacElectric CountershockFemaleFollow-Up StudiesGermanyHeart FailureHumansMaleMiddle AgedPrognosisRetrospective StudiesRisk AssessmentRisk FactorsSecondary PreventionCancerHeart failureImplantable cardioverter defibrillatorInfectionProceduresPrognosisSudden death

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.